Global Custom Market Research Reports Provider Company

phone

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria

  • Published Date: 01 Jun 2018
  • Number of Pages: 135
  • Category: Pharmaceuticals
  • Country: Austria

20%

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Austria. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Austria. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

Austria is one of the largest healthcare markets, with a strong focus on pharmaceutical R&D. The value of the Austrian pharmaceutical market declined from $3.30 billion in 2010 to $3.23 billion in 2016, at a negative compound annual growth rate (CAGR) of 0.33%. However, in terms of Euro, the market value increased from 2.48 billion in 2010 to 2.87 billion in 2017, at a CAGR of 2%. The decline in the market value in Euro terms was driven by the fluctuations in the exchange rate of the Euro versus the US dollar and increased consumption of generics. The Austrian medical device market was valued at $1.63 billion in 2010 and increased to $1.95 billion in 2017.The main segments were nephrology and urology devices, orthopedic devices, ophthalmic devices, cardiovascular devices, and in vitro diagnostics. The robust healthcare system, high focus on R&D and change in demographics are expected to drive the growth of the pharmaceutical market. However, generic substitution and shortage of specialized staff act as a major barrier for the pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Austria, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Pfizer, Merck, Sanofi and Gerot Lannach) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, Roche, DePuy and Sanochemia Pharmazeutika)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Austria
- Porters five forces analysis for pharmaceutical and medical devices market of Austria
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Austrian healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Austrian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Austrian healthcare market.
Publisher Name : GlobalData

Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porters Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List Of Tables

List of Tables
Table 1: Pharmaceutical Market, Austria, Sales of Patented Drug Products by Major Therapeutic Class ($m), 2016 21
Table 2: Medical Device Market, Austria, Revenue by Segment 41
Table 3: Nephrology and Urology Devices Market, Austria, Revenue and Market Share of Major Players 42
Table 4: Orthopedic Market, Austria, Revenue and Market Share of Major Players 43
Table 5: Ophthalmic Devices Market, Austria, Revenue and Market Share of Major Players 44
Table 6: Cardiovascular Devices, Austria, Revenue and Market Share of Major Players 45
Table 7: InVitro Diagnostics Devices Market, Austria, Revenue and Market Share of Major Players 46
Table 8: Market Authorization Fees, 2017, Austria 87
Table 9: Patent Fees, 2017, Austria 98
Table 10: Criteria for New Pharmacy Establishment, Austria 104
Table 11: Label of a Pharmaceutical Product, Austria, 2017 106
Table 12: Trade Associations, Austria 117
Table 13: Trade Fairs, Austria 118

List Of Figures

List of Figures
Figure 1: Pharmaceutical Market, Austria, Revenue, 2009-2016 8
Figure 2: Medical Device Market, Austria, Revenue, 2009-2016 8
Figure 3: Generics Market Share (by value), Austria, Sales (%), 2015 8
Figure 4: Number of Deals (2017-2018) 12
Figure 5: 2017-2018 Deal Overview By Region 12
Figure 6: Country Profile, Austria, 2017 14
Figure 7: Pharmaceutical Market, Austria, Revenue, 2010-2017 16
Figure 8: Pharmaceutical Market, Austria, Revenue Forecast, 2018-2022 16
Figure 9: Pharmaceutical Market, Austria, Pharmaceutical Exports 17
Figure 10: Pharmaceutical Market, Austria, Top Export Partners 17
Figure 11: Pharmaceutical Market, Austria, Pharmaceutical Imports 18
Figure 12: Pharmaceutical Market, Austria, Top Import Partners 18
Figure 13: Pharmaceutical Market, Austria, Supply Channels 19
Figure 14: Pharmaceutical Market, Austria, Sales of Patented Drug Products by Major Therapeutic Class, 2016 21
Figure 15: Pharmaceutical Market, Austria, Major Players 23
Figure 16: Medical Device Market, Austria, Revenue 40
Figure 17: Medical Device Market, Austria, Revenue Forecast 40
Figure 18: Medical Device Market, Austria, Revenue by Segment 41
Figure 19: Nephrology and Urology Devices Market, Austria, Revenue 42
Figure 20: Nephrology and Urology Devices Market, Austria, Market Share of Major Players 42
Figure 21: Orthopedic Devices Market, Austria, Revenue 43
Figure 22: Orthopedic Devices Market, Austria, Market Share of Major Players 43
Figure 23: Ophthalmic Devices Market, Austria, Revenue 44
Figure 24: Ophthalmic Devices Market, Austria, Market Share of Major Players 44
Figure 25: Cardiovascular Market, Austria, Revenue 45
Figure 26: Cardiovascular Market, Austria, Market Share of Major Players 45
Figure 27: InVitro Diagnostics Market, Austria, Revenue 46
Figure 28: InVitro Diagnostics Market, Austria, Market Share of Major Players 46
Figure 29: Medical Device Market, Austria, Revenue of Major Players 48
Figure 30: Deal Value and Deal Count, Pharmaceutical Market, Austria, 2017-2018 68
Figure 31: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Austria, 2017-2018 68
Figure 32: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Austria, 2017-2018 68
Figure 33: Top Five Therapy Area by Deal Value, Pharmaceutical Market, Austria, 2017-2018 69
Figure 34: Top Five Therapy Area by Deal number, Pharmaceutical Market, Austria, 2017-2018 69
Figure 35: M&A Deals by Therapy Area, Pharmaceutical Market, Austria, 2017-2018 (by value and by number) 69
Figure 36: Venture Financing Deals by Therapy Area, Pharmaceutical Market, Austria, 2017-2018 (by value and by number) 69
Figure 37: Private Equity Deals by Therapy Area, Pharmaceutical Market, Austria, 2017-2018 (by value and by number) 69
Figure 38: Medical Device Market Deals, Austria, 2017-2018 (by deal value, $m) 70
Figure 39: Medical Device Market Deals, Austria, 2017- 2018 (by deal count) 70
Figure 40: Medical Device Market Deals Share (by deal count), Austria, 2017-2018 70
Figure 41: Medical Device Market Deals Share (by deal value), Austria, 2017-2018 70
Figure 42: Top Therapy Area by Deal Value, Medical Device, Austria, 2017-2018 71
Figure 43: Top Therapy Area by Deal Number, Medical Device, Austria, 2017-2018 71
Figure 44: M&A Deals by Therapy Area, Medical Device, Austria, 2017-2018 (by value and by number) 71
Figure 45: Venture Financing Deals by Therapy Area, Medical Device, Austria, 2017-2018 (by value and by number) 71
Figure 46: Private Equity Deals by Therapy Area, Medical Device Austria, 2017-2018 (by value and by number) 71
Figure 47: Healthcare System, Austria 76
Figure 48: Drug Funding and Reimbursement Approval Process, Austria 78
Figure 49: Austrian Social Security System, Austria 80
Figure 50: Services of Social Health Insurance, Austria 81
Figure 51: Out-of-Pocket Expenditure (% of total expenditure on health) 83
Figure 52: Pharmaceutical and Consumer Price Index 83
Figure 53: Federal Ministry of Health, Organization Chart, Austria 85
Figure 54: Centralized Procedure, 2017, Austria 88
Figure 55: Decentralized Procedure, 2017, Austria 89
Figure 56: Decentralized Procedure, 2017, Austria 89
Figure 57: Mutual Recognition Procedure, 2017, Austria 90
Figure 58: Conformity Assessment of Class I Medical Devices, EU, 2017 92
Figure 59: Conformity Assessment of Class IIa Medical Devices, EU, 2017 93
Figure 60: Conformity Assessment of Class IIb Medical Devices, EU, 2017 94
Figure 61: Conformity Assessment of Class III Medical Devices, EU, 2017 95
Figure 62: European Patent Approval Process, EU, 2017 99
Figure 63: Unitary Patent Approval Process, EU, 2017 100
Figure 64: Trademark Approval Process, Austria, 2018 101
Figure 65: Clinical Trial Process, Austria, 2017 102
Figure 66: Number of Hospitals, Austria, 2010-2017 109
Figure 67: Diagnostic Equipment, Austria, 2010-2017 109
Figure 68: Hospital Beds (per 1,000 population), Austria 110
Figure 69: Acute Care Hospital Beds (per 1,000 population), Austria 110
Figure 70: Psychiatric Hospital Beds (per 1,000 population), Austria 110
Figure 71: Life Expectancy, 2010-2017, Austria 111
Figure 72: Immunization Rate (%), 2010-2017, Austria 111
Figure 73: PM2.5 (g per m3), Austria, 2010-2016 112
Figure 74: CO2 Emissions (million tons), Austria, 2010-2016 112
Figure 75: Physicians (per 1,000 population), Austria, 2010-2016 113
Figure 76: Nurses (per 1,000 population), Austria, 2010-2016 113
Figure 77: Dentists (per 1,000 population), Austria, 2010-2016 113
Figure 78: Pharmacists (per 1,000 population), Austria, 2010-2016 113
Figure79: Major Causes of Mortality (per 100,000 population), Austria, 2015 114
Figure 80: Major Causes of Male Mortality, Austria, 2015 114
Figure 81: Major Causes of Female Mortality, Austria, 2015 114
Figure 82: Disability-Adjusted Life Years by Major Disease (000), Austria, 2016 114
Figure 83: Healthcare Expenditure as Percentage of GDP (%), Austria, 2010-2017 115
Figure 84: Public-Private Share (%), Austria, 2010-2016 115
Figure 85: Major Components of Healthcare Spending (%), Austria, 2016 116
Figure 86: Opportunities and Challenges, Austria 120

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria . The report is an essential

View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Switzerland GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Switzerland . The report is an essential

View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Norway GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Norway . The report is an essential

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports